N-Fmoc-4-methylbenzyl-glycine combines a para-methyl aromatic group with glycine flexibility, offering hydrophobic modulation. The residue influences packing interactions and side-chain orientation in engineered peptides. Researchers use it to probe aromatic tuning and linker spacing. Its Fmoc protection supports accurate solid-phase incorporation.
CAT No: R2147
CAS No:2137684-15-0
Synonyms/Alias:N-Fmoc-4-methylbenzyl-glycine;2137684-15-0;{[(9H-fluoren-9-ylmethoxy)carbonyl][(4-methylphenyl)methyl]amino}acetic acid;EN300-657848;F80942;2-[9H-fluoren-9-ylmethoxycarbonyl-[(4-methylphenyl)methyl]amino]acetic acid;2-({[(9H-fluoren-9-yl)methoxy]carbonyl}[(4-methylphenyl)methyl]amino)acetic acid;
N-Fmoc-4-methylbenzyl-glycine is a specialized amino acid derivative widely recognized for its utility in peptide synthesis and chemical research. Featuring an N-terminal fluorenylmethyloxycarbonyl (Fmoc) protecting group and a 4-methylbenzyl substituent on the glycine residue, this compound offers unique steric and electronic properties that can be leveraged in the design of complex peptide sequences. Its structural attributes facilitate selective modification and incorporation into growing peptide chains, making it highly valuable for researchers seeking to introduce non-canonical functionalities or enhance peptide stability. The compatibility of N-Fmoc-4-methylbenzyl-glycine with standard solid-phase peptide synthesis (SPPS) protocols further enhances its appeal, ensuring reliable performance in automated and manual synthesis workflows.
Peptide Synthesis: N-Fmoc-4-methylbenzyl-glycine serves as a building block in the construction of custom peptides, particularly when the introduction of a bulky side chain is desired to modulate peptide conformation or function. By incorporating this derivative into peptide sequences, researchers can influence the overall structure, hydrophobicity, and biological properties of the resulting peptides. The Fmoc protecting group allows for efficient stepwise assembly using SPPS, ensuring that the 4-methylbenzyl substituent remains intact until selective deprotection is required. This precise control over functional group exposure is critical for the synthesis of peptides with defined sequences and properties.
Peptidomimetic Design: In the development of peptidomimetics, which are molecules designed to mimic the structure and function of peptides, 4-methylbenzyl-glycine derivatives are often employed to introduce rigidity or hydrophobic character into target molecules. The presence of the methylbenzyl group can restrict conformational flexibility, thereby stabilizing bioactive conformations or enhancing resistance to enzymatic degradation. This makes the compound an attractive choice for researchers aiming to develop peptide-like molecules with improved pharmacological profiles or enhanced target specificity.
Structure-Activity Relationship Studies: The unique side chain of N-Fmoc-4-methylbenzyl-glycine allows scientists to systematically investigate the impact of steric and electronic modifications on peptide activity. By substituting glycine or other residues with this derivative, researchers can probe the influence of side-chain bulk and aromaticity on receptor binding, enzymatic recognition, or overall biological function. Such studies are essential for elucidating the molecular determinants of peptide activity and guiding the rational design of next-generation therapeutic candidates or biochemical tools.
Combinatorial Library Construction: The compound's compatibility with automated peptide synthesizers and its distinctive side chain make it a valuable component in the creation of combinatorial peptide libraries. By incorporating N-Fmoc-4-methylbenzyl-glycine at variable positions within diverse peptide sequences, researchers can generate large collections of molecules for high-throughput screening. This approach accelerates the discovery of novel ligands, inhibitors, or modulators for a wide range of biological targets, supporting advancements in drug discovery and molecular biology.
Biophysical Studies: The introduction of a 4-methylbenzyl group through this glycine derivative enables detailed investigations into peptide folding, aggregation, and intermolecular interactions. By selectively modifying peptide sequences with N-Fmoc-4-methylbenzyl-glycine, scientists can explore how side-chain modifications affect secondary structure formation, stability, and dynamics. Such studies contribute to a deeper understanding of protein folding mechanisms and the design of peptides with tailored biophysical properties for research or industrial applications.
Chemical Biology Research: N-Fmoc-4-methylbenzyl-glycine finds application in chemical biology as a tool for site-specific modification and labeling of peptides. The unique reactivity of the methylbenzyl side chain can be exploited for post-synthetic derivatization or conjugation to probes, fluorophores, or other functional moieties. This enables the creation of customized peptide conjugates for imaging, affinity purification, or mechanistic studies, expanding the toolkit available for probing complex biological systems at the molecular level.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Myotropic activity of allatostatins in tenebrionid beetles
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More